These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
715 related items for PubMed ID: 25092439
1. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection. Ewaisha RE, Bahey-El-Din M, Mossallam SF, Amer EI, Aboushleib HM, Khalil AM. Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439 [Abstract] [Full Text] [Related]
2. Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model. Mossallam SF, Amer EI, Ewaisha RE, Khalil AM, Aboushleib HM, Bahey-El-Din M. BMC Infect Dis; 2015 Mar 24; 15():147. PubMed ID: 25887456 [Abstract] [Full Text] [Related]
3. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. Cardoso FC, Macedo GC, Gava E, Kitten GT, Mati VL, de Melo AL, Caliari MV, Almeida GT, Venancio TM, Verjovski-Almeida S, Oliveira SC. PLoS Negl Trop Dis; 2008 Oct 01; 2(10):e308. PubMed ID: 18827884 [Abstract] [Full Text] [Related]
4. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice. Garcia TC, Fonseca CT, Pacifico LG, Durães Fdo V, Marinho FA, Penido ML, Caliari MV, de Melo AL, Pinto HA, Barsante MM, Cunha-Neto E, Oliveira SC. Acta Trop; 2008 Jun 01; 106(3):162-7. PubMed ID: 18423420 [Abstract] [Full Text] [Related]
5. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection. Gonçalves de Assis NR, Batistoni de Morais S, Figueiredo BC, Ricci ND, de Almeida LA, da Silva Pinheiro C, Martins Vde P, Oliveira SC. PLoS One; 2015 Jun 01; 10(5):e0125075. PubMed ID: 25942636 [Abstract] [Full Text] [Related]
6. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice. Pinheiro CS, Ribeiro AP, Cardoso FC, Martins VP, Figueiredo BC, Assis NR, Morais SB, Caliari MV, Loukas A, Oliveira SC. Parasite Immunol; 2014 Jul 01; 36(7):303-12. PubMed ID: 24749785 [Abstract] [Full Text] [Related]
12. Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice. Varaldo PB, Miyaji EN, Vilar MM, Campos AS, Dias WO, Armôa GR, Tendler M, Leite LC, McIntosh D. FEMS Immunol Med Microbiol; 2006 Oct 01; 48(1):132-9. PubMed ID: 16965361 [Abstract] [Full Text] [Related]
13. Increased immunogenicity and protection of recombinant Sm14 antigens by heat-killed Cutibacterium acnes in BALB/c mice infected with Schistosoma mansoni. Lam HYP, Huang SP, Liang TR, Wu WJ, Cheng PC, Chang KC, Peng SY. Parasitol Int; 2022 Feb 01; 86():102446. PubMed ID: 34481947 [Abstract] [Full Text] [Related]
16. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis. El Ridi R, Tallima H. Vaccine; 2009 Jan 29; 27(5):666-73. PubMed ID: 19056448 [Abstract] [Full Text] [Related]
17. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice. Abreu PA, Miyasato PA, Vilar MM, Dias WO, Ho PL, Tendler M, Nascimento AL. Infect Immun; 2004 Oct 29; 72(10):5931-7. PubMed ID: 15385496 [Abstract] [Full Text] [Related]